Patent Continuation

A continuation application is a new patent application that claims priority to an earlier application: DEFINITION: a continuation (CON) is an application filed while the parent application is still pending; it contains the same disclosure as the parent (no new matter); it can have different (broader, narrower, or different focus) claims than the parent; PRIORITY DATE: the continuation gets the priority date (filing date) of the parent application; this means prior art from between the parent filing date and the continuation filing date cannot be used against the continuation claims; this is the core strategic benefit — the priority date of the original filing; HOW TO FILE: filed as a continuation under 35 U.S.C. § 120 (domestic priority) or § 365(c) (based on PCT parent); must be filed while the parent is still pending (before the parent issues or is abandoned); copendency requirement: the continuation and parent must be copending at the moment of filing; claim the benefit of the parent's filing date in the application data sheet (ADS); WHAT MUST BE THE SAME: the continuation must share the same disclosure as the parent; no new matter can be added (unlike CIP); the SAME specification (or a subset) as the parent; DIFFERENT CLAIMS: the continuation can have entirely different claims than the parent; broader claims (if the parent was too narrow); narrower claims directed to a specific embodiment; claims directed to a different aspect of the same disclosure; STRATEGIC VALUE: allows patent owners to continue examining different claim scopes for the same disclosure; allows filing claims directed to competitors' products after they launch (continuation 'watching' strategy); creates multiple patents from a single disclosure; keeps prosecution open during licensing negotiations (maintaining uncertainty about the full scope of protection).

A continuation-in-part (CIP) adds new matter to the parent application's disclosure: DEFINITION: a CIP is an application that: discloses all of the subject matter of the parent application; AND adds new subject matter not disclosed in the parent; CIP vs. CONTINUATION: continuation: same disclosure, different claims; CIP: expanded disclosure with new matter, potentially different claims; THE CRITICAL DISTINCTION — PRIORITY DATE: claims in a CIP have SPLIT priority dates depending on what each claim requires: claims supported ONLY by the parent disclosure: get the parent's priority date; claims requiring subject matter found ONLY in the new CIP matter: get the CIP's filing date; this distinction determines what prior art applies to each claim; PRACTICAL CONSEQUENCE: if a third party publishes a paper AFTER the parent but BEFORE the CIP filing that describes the new matter, that publication is prior art AGAINST claims that require the new CIP matter; it is NOT prior art against claims fully supported by the parent; WHEN TO USE A CIP: improvements made after the original filing but closely related to the parent invention; the inventor made improvements or discovered additional embodiments after the parent was filed; want to add new biological or chemical data obtained after the initial filing; want to capture an improvement in a single continuing application family rather than filing a separate new application; ALTERNATIVE TO CIP: filing a new independent application (new nonprovisional): same or similar disclosure with new matter; no priority claim to the parent; the new application starts fresh; advantage: no tainted priority date issue; simpler prosecution history; disadvantage: no connection to the parent patent family; ANTI-SUBMARINE CONCERN: CIPs kept the patent family alive during which a continuation claim could be filed directed at a competitor's product (pre-GATT, pre-1995); post-GATT, the 20-year term runs from the earliest priority date, limiting the value of prolonged CIP prosecution.

Divisional applications separate out claims that cover distinct inventions: RESTRICTION REQUIREMENT: the USPTO issues a restriction requirement when an application claims two or more distinct and independent inventions; the applicant must 'elect' one invention to prosecute in the current application; the other inventions are 'non-elected'; DIVISIONAL AS RESPONSE TO RESTRICTION: after electing one invention in the parent, the applicant can file a divisional application directed to the non-elected invention; the divisional gets the same filing date as the parent; no new matter can be added; THE UNITY OF INVENTION CONCEPT AT EPO: the European Patent Office does not use restriction requirements in the same way; EPO uses 'unity of invention' — claims must relate to a single inventive concept; EPO can require a divisional to be filed for non-unified claims, but it is handled differently than USPTO restriction; WHAT COUNTS AS 'DISTINCT AND INDEPENDENT': USPTO uses the 'combination-subcombination' and 'product-process-apparatus' tests; two inventions are 'distinct and independent' if: there is no single claim embracing both; each invention, if practiced, does not necessarily practice the other; TRAVERSING A RESTRICTION: applicants can 'traverse' (object to) a restriction requirement; argue that the inventions are not distinct or not independent; rarely successful but creates record in the prosecution history; STRATEGIC DIVISIONAL FILING: even without a restriction requirement, applicants can file a divisional voluntarily (but must respect the subject-matter limits of the parent); some applicants file divisionals to develop different claim aspects of a complex disclosure; PROSECUTION DISCLAIMER IN DIVISIONALS: statements made during prosecution of the parent can limit the scope of claims in related divisionals under the 'prosecution disclaimer' doctrine.

Prosecution laches limits a patent owner's ability to exploit continuation practice opportunistically: THE DOCTRINE: prosecution laches is an equitable defense to patent enforcement; it applies when a patent owner unreasonably delays prosecution of a continuation or other continuing application, and the delay causes prejudice to accused infringers; SYMBOL TECHNOLOGIES v. LEMELSON (Fed. Cir. 2004): a landmark case where machine vision patents held by Jerome Lemelson (with continuation chains 25-50+ years long) were held unenforceable for prosecution laches; Lemelson had filed continuation applications over decades, allowing his patent family to cover technologies developed long after his original inventions; defendants had invested in technologies for years before the submarine patents issued; WHAT PROSECUTION LACHES REQUIRES: unreasonable and inexcusable delay in prosecution; prejudice to the accused infringer (e.g., established technology, investments made in reliance on patent-free status); Lemelson's delays were extreme (decades); PREVENTING PROSECUTION LACHES: file continuation claims promptly after the parent issues or after relevant competitors enter the market; do not maintain pending applications purely to threaten potential licensees without legitimate claim prosecution; continue examination in good faith; CONTINUATION WATCHING STRATEGY: many companies maintain one or more continuation applications in each major patent family; this allows new claims to be filed if a competitor develops a design-around; the key: continue prosecuting in good faith; do not let applications sit idle for years; POST-AIA LIMITATION: the AIA did not directly change continuation practice; but the AIA's 20-year patent term from the filing date limits the strategic value of prolonged continuation chains (pre-GATT submarine patents had 17-year terms from issue, not from filing — this created strong incentives to delay).

Effective continuation management requires systematic strategy: PORTFOLIO BUILDING STRATEGY: for major product inventions, plan to file at least one continuation after the parent issues; anticipate competitor design-arounds and draft continuation claims to cover reasonable alternatives before filing; consider filing both broader and narrower claims in different continuations; TIMING: continuation must be filed while the parent is pending (before issue or abandonment); after the parent issues, a continuation requires copendency — file before parent issues; the day the parent issues, the window for a conventional continuation closes (though a continuation-in-part or new application is still possible); PROSECUTION COORDINATION: track all continuation applications in the family; maintain consistent claim construction positions across the family (prosecution disclaimer can bleed across related applications); coordinate office action responses to avoid creating inadvertent estoppel that applies to the whole family; TERMINAL DISCLAIMERS IN CONTINUATIONS: if continuation claims are obvious variants of the parent claims, the USPTO may issue a double-patenting rejection; resolution: file a terminal disclaimer (linking the continuation's term to the parent's term — both expire together); CONTINUATION VERSUS RCE: both continue prosecution of claims; RCE: same application number; consumes PTA (C-delay); stays within the same patent; continuation: new application number; new 20-year term from continuation filing date; more claims possible; generally preferred over repeated RCEs for complex prosecution; LICENSING AND ENFORCEMENT: continuation applications provide a 'sword of Damocles' over potential infringers — the full scope of the continuing family is not known until all applications issue; some companies disclose the existence of pending continuations during licensing negotiations to increase settlement pressure; RECORD KEEPING: maintain a clean record of all continuation family relationships; track earliest effective filing date for each claim; document all restriction requirements and divisional elections.